Presented By: Paul Goepfert
Speaker Biography: Dr. Goepfert holds the Edward W. Hook III, MD Endowed Professorship in Infectious Diseases in the Department of Medicine at the University of Alabama at Birmingham (UAB) and the Director of the Alabama Vaccine Research Clinic (AVRC). His laboratory research interests are focused on T cell immunology and vaccine design. He has recently begun analyzing T cell responses to COVID-19 using samples obtained from patients at UAB. Dr. Goepfert's clinical research interest is centered on the testing of preventative vaccines through the AVRC which has previously focused on HIV but now is studying COVID-19 vaccines as well. He has also overseen vaccines trials designed to prevent anthrax, HPV, HBV, influenza, and small pox. He is authored over 140 peer-reviewed papers largely focused on immunology and vaccines.
Webinar: The Rapid Development of COVID-19 Vaccines
Webinar Abstract: Vaccines to prevent COVID-19 were developed within 1 year after the identification of SARS-CoV-2 as the causative virus. There are now 3 vaccines that are FDA approved via Emergency Use Authorization. This talk will highlight how one of those vaccines was developed. It will focus on how rapid development of the vaccines were attained while still testing them rigorously for safety. It will also show how these vaccines work as well as present safety, efficacy, and immune data. It will end with a brief discussion on which vaccines have been developed and shown to be effective in preventing COVID-19 across the world.
Earn PACE Credits:
1. Make sure you're a registered member of LabRoots [ Ссылка ]
2. Watch the webinar on the LabRoots Website [ Ссылка ]
3. Click Here to get your PACE credits (04/14/2023): [ Ссылка ]
LabRoots on Social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Pinterest: [ Ссылка ]
SnapChat: labroots_inc
